# Mylan Technologies, Inc., Saint Albans, VT – FDA Inspections

Source: https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70

> Inspection records and compliance data for Mylan Technologies, Inc. in Saint Albans, Vermont. 9 FDA inspections on record (1 OAI), 1 Form 483, last inspected October 21, 2025.

---

## Details

- Name: Mylan Technologies, Inc.
- FEI Number: 1220747
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: 110 Lake St
- City: Saint Albans
- State: Vermont
- Zip Code: 05478
- Country Name: United States
- Address: 110 Lake St, Saint Albans, Vermont 05478, United States
- Country: United States

## Related Documents

- FDA Inspection 1285894 - Mylan Technologies, Inc. - 2025-10-21 — source: FDA, date: October 21, 2025
- FDA Inspection 1285894 - Mylan Technologies, Inc. - 2025-10-21 — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2025
- FDA Inspection 1226467 - Mylan Technologies, Inc. - 2023-12-18 — source: FDA, date: December 18, 2023
- FDA Inspection 1133997 - Mylan Technologies, Inc. - 2020-11-20 — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2020
- FDA Inspection 1065833 - Mylan Technologies, Inc. - 2018-08-15 — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2018
- [FDA Inspection 1026374 - Mylan Technologies, Inc. - 2017-09-14](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/1626456b-8b63-4491-a40b-496bc50eb84d) — classification: Official Action Indicated (OAI), source: FDA, date: September 14, 2017
- FDA Inspection 970691 - Mylan Technologies, Inc. - 2016-04-13 — classification: No Action Indicated (NAI), source: FDA, date: April 13, 2016
- FDA Inspection 836096 - Mylan Technologies, Inc. - 2013-04-30 — classification: No Action Indicated (NAI), source: FDA, date: April 30, 2013
- FDA Inspection 750943 - Mylan Technologies, Inc. - 2011-10-31 — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2011
- FDA Inspection 667710 - Mylan Technologies, Inc. - 2010-06-04 — classification: No Action Indicated (NAI), source: FDA, date: June 4, 2010

## Related Companies

- [Avara Pharmaceutical Technologies, Inc.](https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [Braintree, A part of SEBELA Pharmaceuticals](https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2)
- [DPT Laboratories Ltd.](https://www.keypedia.com/companies/dpt-laboratories-ltd/3b2d6611-9567-4aa0-8e8c-25e1e0a1714e)
- [HIBROW HEALTHCARE PRIVATE LIMITED](https://www.keypedia.com/companies/hibrow-healthcare-private-limited/c5de7b11-f0fd-48a0-9bf9-e7730c9dc8fe)
- [AstraZeneca Dunkerque Production (AZDP)](https://www.keypedia.com/companies/astrazeneca-dunkerque-production-azdp/581c1e69-c574-45d9-a5e0-a263fc2e4c6c)
- [Glaropharm Ag](https://www.keypedia.com/companies/glaropharm-ag/c7d66974-1066-4007-909d-51c27de7cc95)
- [A. R. LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/a-r-life-sciences-private-limited/489d62fd-f360-42e9-a3f9-a49fcdf8dfcb)
